Atlas Trials

Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)

Clinical trial NCT05974839 · COMPLETED

Trial details

NCT number
NCT05974839
Sponsor
State University of New York at Buffalo
Status
COMPLETED
Study type
OBSERVATIONAL
Primary Progressive Multiple Sclerosis
Start date
2023-10-01
Primary completion
2024-02-28
Enrollment
732

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.